The minimum viable stack (MVS) is the smallest set of supplement changes that can plausibly move a specific outcome, while keeping safety, attribution, and measurement manageable.
Why it matters
More ingredients mean more noise, not more results. The MVS protects you from two failure modes: adding so much that you can't identify what worked, and adding so little that you call a protocol a failure when you never gave it a fair test.
The core principle
An MVS is not "doing the bare minimum." It is disciplined scope: one clearly defined goal, one to two active ingredients, and a measurement plan that will actually detect a change if one occurs.
What MVS looks like in practice
A practical MVS nearly always contains:
- one foundation item (only if a genuine gap exists)
- one goal-specific ingredient with the best evidence-to-risk ratio for your outcome
- nothing else until you have a reviewable result
When to add complexity
Add complexity only when:
- the current stack produced a reviewable result (positive or null)
- adherence was above 90% during the test window
- you can explain in plain terms why the new item would change the outcome
Common MVS examples by goal
- Strength and training performance: creatine monohydrate alone
- Sleep onset: timed melatonin alone
- Focus without jitters: caffeine at a controlled dose, with optional L-theanine
- Stress adaptation: standardized ashwagandha extract alone
Practical action step
Write down your stack before you start it. If you cannot explain each ingredient's role in one sentence, it is not yet minimal.
Uncertainty and limits
- Evidence is limited on what the "minimum" threshold is for any individual; some people need more than a minimal dose to detect a real effect.
- Evidence is limited on how long a minimum viable trial should be; time-to-effect varies considerably by compound class.
Cross-site references
How this appears in Unfair
The platform favors conservative, single-ingredient-first stack builds. The recommendation engine ranks low-complexity options higher when starting context is limited.
Clinical safety note
A smaller stack is usually a safer stack. If you are managing medications or a chronic condition, the MVS principle is especially important: fewer simultaneous changes mean fewer attribution errors when something goes wrong.